MENU
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2025 All rights reserved. Tickeron Inc.
ABBV
Stock ticker: NYSE
PRICE
CHANGE
CAPITALIZATION

ABBVIE (ABBV) Ownership - Who owns ABBVIE?

AbbVie is a pharmaceutical firm with a strong exposure to immunology (with Humira, Skyrizi, and Rinvoq) and oncology (with Imbruvica and Venclexta)... Show more

#MovingAverage#Momentum#MACD#Pattern#RSI#Stochastic#Aroon#Bollinger

Profile

Industry
Pharmaceuticals Major
Address
1 North Waukegan Road
Phone
+1 847 932-7900
Employees
50000
Web
http://www.abbvieinvestor.com

Details

Group
Domestic Stock Funds
Category
Pharmaceuticals
Capitalization
349.87B
P/E Ratio
94.31
Total Cash
N/A
Projected Growth
0.42
Total Debt
69.89B
Revenue
N/A
Risk (Beta)
0.27
Dividend Yield
0.03
Total Cash/Share
N/A
Total Debt/Equity
314.07
Revenue/Share
32.90 USD as % of share price

Fundamentals

ABBV
Capitalization
350B
P/E Ratio
94.31
Risk (Beta)
0.27
Dividend Yield
0.03
Total Cash
N/A
Total Cash/Share
N/A
Total Debt
69.9B
Total Debt/Equity
314.07
Projected Growth (PEG Ratio)
0.42
Revenue/Share (as % of the share price)
32.90%
Revenue
N/A
ROE
N/A
Book Value
1.42B
P/B Ratio
243.90
Cash Flow
N/A
Earnings
N/A
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
18M
Current Ratio
0.76
Current Revenue Per Employee
242600.00
Dividends Per Share - Security
1.64
EBITDA
N/A
Float
N/A
Float - Current
N/A
Gross Income Margin
70.01
Revenue To Assets
N/A
Shares Held By Institutions
632B
Shares Outstanding - Current
1.77B
Total Liabilities
7.06B
Total Volume MTD
N/A
Value
-1
Gain YTD
14.523
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
Day Trader: Search for Dip TA&FA ($1500)Day Trader: Search for Dip TA&FA ($1500)
Annualized Return+11%
VIEW DETAILSVIEW DETAILS
VIEW FOR FREEVIEW FOR FREE
ABBV
TickeronSetup
Buy or SellView
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View Trends For ABBV
(Try 14 days for Free)
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. ABBV showed earnings on July 31, 2025. You can read more about the earnings report here.
View AI-Driven Trading
A.I. Advisor
published General Information

General Information

a research-based pharmaceutical company

Industry PharmaceuticalsMajor

Profile
Fundamentals
Details
Industry
Pharmaceuticals Major
Address
1 North Waukegan Road
Phone
+1 847 932-7900
Employees
50000
Web
http://www.abbvieinvestor.com